Company
ActiveModerna
Cambridge, Massachusetts · Since 2010
Still independent. Its messenger-RNA platform was a research bet until the COVID-19 vaccine made it a manufacturer.
Moderna was founded in 2010 in Cambridge, Massachusetts, to turn messenger RNA into medicine. For a decade that was a research program with a payroll of scientists and almost no product a patient could receive.
The COVID-19 vaccine changed the company into a manufacturer. A process that had lived in a lab had to be repeated at a scale of hundreds of millions of doses, in plants, with a cold chain and a regulatory file. The jobs appeared in months.
From sequence to vial
The new work was manufacturing science: people who could run a bioreactor, fill a vial, and document every step so a regulator would accept it. Moderna hired and contracted that capacity without having been a factory company. The public saw a scientific miracle. The employment story is the less told one, a crash course in how a dose becomes a thing that can be shipped.
A company after the emergency
Moderna is still independent. Revenue fell when the emergency orders ended, and the company returned to being, in large part, a research employer with a manufacturing capability it now has to keep busy. It belongs in the 2020 chapter because for two years it was a factory the world was watching, not because a vaccine company is a permanent new industry of that size.
The work it organized
- Research scientist
- Manufacturing technician
- Quality reviewer
- Fill-finish operator
On the timeline
Related
- BioNTechActive